
First Drug to Delay Type 1 Diabetes Onset Approved for NHS Use
The UK's NHS will offer teplizumab, the world's first drug to delay the onset of type 1 diabetes. Approved for adults and children aged 8+, it trains the immune system to protect pancreatic cells, postponing symptomatic disease for up to three years.





